{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:54:52Z","timestamp":1793836492989,"version":"4.6.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T00:00:00Z","timestamp":1771113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T00:00:00Z","timestamp":1771113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-026-08344-z","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T09:04:12Z","timestamp":1771146252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Correlation of blood lipid levels with the severity of polycystic ovary syndrome and its predictive value for pregnancy outcome"],"prefix":"10.1007","volume":"313","author":[{"given":"Dongting","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,15]]},"reference":[{"issue":"1","key":"8344_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva D, Suturina L, Walker W et al (2016) Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 106(1):6\u201315","journal-title":"Fertil Steril"},{"issue":"9","key":"8344_CR2","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1093\/humrep\/det262","volume":"28","author":"R Li","year":"2013","unstructured":"Li R, Zhang Q, Yang D et al (2013) Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod 28(9):2562\u20132569","journal-title":"Hum Reprod"},{"issue":"9","key":"8344_CR3","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","volume":"10","author":"AE Joham","year":"2022","unstructured":"Joham AE, Norman RJ, Stener-Victorin E et al (2022) Polycystic ovary syndrome. Lancet Diabetes Endocrinol 10(9):668\u2013680. https:\/\/doi.org\/10.1016\/S2213-8587(22)00163-2. (Erratum in: Lancet Diabetes Endocrinol. 2022 Nov;10(11):e11.)","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"8344_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s42000-023-00438-6","volume":"22","author":"L Zhang","year":"2023","unstructured":"Zhang L, Wang H, Ma Q et al (2023) Value of the triglyceride-glucose index and non-traditional blood lipid parameters in predicting metabolic syndrome in women with polycystic ovary syndrome. Hormones 22(2):263\u2013271","journal-title":"Hormones"},{"issue":"1","key":"8344_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12958-018-0346-x","volume":"16","author":"K Yang","year":"2018","unstructured":"Yang K, Zeng L, Bao T et al (2018) Effectiveness of Omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol 16(1):27","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"8344_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1530\/REP-17-0584","volume":"155","author":"R Patel","year":"2018","unstructured":"Patel R, Shah G (2018) High-fat diet exposure from pre-pubertal age induces polycystic ovary syndrome (PCOS) in rats. Reproduction 155(2):141\u2013151","journal-title":"Reproduction"},{"issue":"4","key":"8344_CR7","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.fertnstert.2017.01.017","volume":"107","author":"DE Broughton","year":"2017","unstructured":"Broughton DE, Moley KH (2017) Obesity and female infertility: potential mediators of obesity\u2019s impact. Fertil Steril 107(4):840\u2013847","journal-title":"Fertil Steril"},{"issue":"3","key":"8344_CR8","doi-asserted-by":"publisher","first-page":"20180002","DOI":"10.1515\/hmbci-2018-0002","volume":"34","author":"V Pergialiotis","year":"2018","unstructured":"Pergialiotis V, Trakakis E, Chrelias C et al (2018) The impact of mild hypercholesterolemia on glycemic and hormonal profiles, menstrual characteristics and the ovarian morphology of women with polycystic ovarian syndrome. Horm Mol Biol Clin Investig 34(3):20180002","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"1","key":"8344_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12944-018-0688-6","volume":"17","author":"A Imran","year":"2018","unstructured":"Imran A, Butt MS, Arshad MS et al (2018) Exploring the potential of black tea based flavonoids against hyperlipidemia related disorders. Lipids Health Dis 17(1):57","journal-title":"Lipids Health Dis"},{"issue":"11","key":"8344_CR10","doi-asserted-by":"publisher","first-page":"5697","DOI":"10.19082\/5697","volume":"9","author":"AA Shaman","year":"2017","unstructured":"Shaman AA, Mukhtar HB, Mirghani HO (2017) Risk factors associated with metabolic syndrome and cardiovascular disease among women with polycystic ovary syndrome in Tabuk Saudi Arabia. Electron Physician 9(11):5697\u20135704","journal-title":"Electron Physician"},{"issue":"8","key":"8344_CR11","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.25122\/jml-2023-0040","volume":"16","author":"SRM Hussein","year":"2023","unstructured":"Hussein SRM, Sadiq AM, Johar SA et al (2023) Insulin level, lipid profile, and HOMA index in lean and obese patients with polycystic ovary syndrome. J Med Life 16(8):1258\u20131263","journal-title":"J Med Life"},{"issue":"12","key":"8344_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.773781","volume":"5","author":"H He","year":"2022","unstructured":"He H, Feng J, Zhang S et al (2022) The apolipoprotein B\/A1 ratio is associated with metabolic syndrome components, insulin resistance, androgen hormones, and liver enzymes in women with polycystic ovary syndrome. Front Endocrinol (Lausanne) 5(12):773781","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"8344_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1447-0756.2012.01907.x","volume":"39","author":"Q Yin","year":"2013","unstructured":"Yin Q, Chen X, Li L et al (2013) Apolipoprotein B\/apolipoprotein A1 ratio is a good predictive marker of metabolic syndrome and pre-metabolic syndrome in Chinese adolescent women with polycystic ovary syndrome. J Obstet Gynaecol Res 39(1):203\u2013209","journal-title":"J Obstet Gynaecol Res"},{"issue":"8","key":"8344_CR14","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1093\/humrep\/des191","volume":"27","author":"J Zhang","year":"2012","unstructured":"Zhang J, Fan P, Liu H et al (2012) Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS. Hum Reprod 27(8):2484\u20132493","journal-title":"Hum Reprod"},{"issue":"9","key":"8344_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1161\/CIRCULATIONAHA.121.057807","volume":"146","author":"E Hagstr\u00f6m","year":"2022","unstructured":"Hagstr\u00f6m E, Steg PG, Szarek M et al (2022) Apolipoprotein B, residual cardiovascular risk after acute coronary syndrome, and effects of alirocumab. Circulation 146(9):657\u2013672","journal-title":"Circulation"},{"issue":"42","key":"8344_CR16","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1093\/eurheartj\/ehab432","volume":"42","author":"R Quispe","year":"2021","unstructured":"Quispe R, Martin SS, Michos ED et al (2021) Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study. Eur Heart J 42(42):4324\u20134332","journal-title":"Eur Heart J"},{"issue":"13","key":"8344_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.892125","volume":"4","author":"F Guo","year":"2022","unstructured":"Guo F, Gong Z, Fernando T et al (2022) The lipid profiles in different characteristics of women with PCOS and the interaction between dyslipidemia and metabolic disorder states: a retrospective study in Chinese population. Front Endocrinol (Lausanne) 4(13):892125","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"8344_CR18","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1021\/pr3000317","volume":"11","author":"L Sun","year":"2012","unstructured":"Sun L, Hu W, Liu Q et al (2012) Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients. J Proteome Res 11(5):2937\u20132946","journal-title":"J Proteome Res"},{"issue":"3","key":"8344_CR19","first-page":"970","volume":"102","author":"DF Vine","year":"2017","unstructured":"Vine DF, Wang Y, Jetha MM et al (2017) Impaired ApoB-lipoprotein and triglyceride metabolism in obese adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 102(3):970\u2013982","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"8344_CR20","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12967-024-05167-x","volume":"22","author":"Y Qian","year":"2024","unstructured":"Qian Y, Tong Y, Zeng Y et al (2024) Integrated lipid metabolomics and proteomics analysis reveal the pathogenesis of polycystic ovary syndrome. J Transl Med 22(1):364","journal-title":"J Transl Med"},{"issue":"1","key":"8344_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19\u201325","journal-title":"Fertil Steril"},{"issue":"10","key":"8344_CR22","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","volume":"108","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJE et al (2023) Recommendations from the 2023 International evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab 108(10):2447\u20132469","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"8344_CR23","first-page":"434","volume":"39","author":"K Szosland","year":"2019","unstructured":"Szosland K, Karzkowiak A, Lewinski A (2019) Metabolic characteristics of women diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria\u2014our own experience. Neuro Endocrinol Lett 39(6):434\u2013440","journal-title":"Neuro Endocrinol Lett"},{"issue":"1","key":"8344_CR24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12905-023-02337-9","volume":"23","author":"M Sang","year":"2023","unstructured":"Sang M, Yu Y, Zhou Z et al (2023) Differential expression of serum mir-363-3p in patients with polycystic ovary syndrome and its predictive value for their pregnancy. BMC Womens Health 23(1):264","journal-title":"BMC Womens Health"},{"key":"8344_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","volume":"182","author":"S Patel","year":"2018","unstructured":"Patel S (2018) Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol 182:27\u201336","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"8344_CR26","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1210\/endrev\/bnac001","volume":"43","author":"M Dapas","year":"2022","unstructured":"Dapas M, Dunaif A (2022) Deconstructing a syndrome: genomic insights into PCOS causal mechanisms and classification. Endocr Rev 43(6):927\u2013965","journal-title":"Endocr Rev"},{"issue":"4","key":"8344_CR27","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/nu5041218","volume":"5","author":"B Klop","year":"2013","unstructured":"Klop B, Elte JW, Cabezas MC (2013) Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 5(4):1218\u20131240","journal-title":"Nutrients"},{"key":"8344_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000341683","volume":"40","author":"D Macut","year":"2013","unstructured":"Macut D, Bjeki\u0107-Macut J, Savi\u0107-Radojevi\u0107 A (2013) Dyslipidemia and oxidative stress in PCOS. Front Horm Res 40:51\u201363","journal-title":"Front Horm Res"},{"issue":"7","key":"8344_CR29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","volume":"18","author":"E Diamanti-Kandarakis","year":"2007","unstructured":"Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA et al (2007) Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab 18(7):280\u2013285","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"8344_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12958-016-0203-8","volume":"14","author":"R Yang","year":"2016","unstructured":"Yang R, Yang S, Li R et al (2016) Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis. Reprod Biol Endocrinol 14(1):67","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"8344_CR31","first-page":"23","volume":"49","author":"GA Abruzzese","year":"2017","unstructured":"Abruzzese GA, Cerrrone GE, Gamez JM et al (2017) Lipid accumulation product (LAP) and visceral adiposity index (VAI) as markers of insulin resistance and metabolic associated disturbances in young argentine women with polycystic ovary syndrome. Horm Metab Res 49(1):23\u201329","journal-title":"Horm Metab Res"},{"issue":"8","key":"8344_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160571","volume":"11","author":"CS G\u00f6bl","year":"2016","unstructured":"G\u00f6bl CS, Ott J, Bozkurt L et al (2016) To assess the association between glucose metabolism and ectopic lipid content in different clinical classifications of PCOS. PLoS ONE 11(8):e0160571","journal-title":"PLoS ONE"},{"issue":"8","key":"8344_CR33","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1080\/01443615.2017.1318840","volume":"37","author":"L Li","year":"2017","unstructured":"Li L, Feng Q, Ye M et al (2017) Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis. J Obstet Gynaecol 37(8):1036\u20131047","journal-title":"J Obstet Gynaecol"},{"issue":"11","key":"8344_CR34","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1210\/jc.2016-2586","volume":"101","author":"DA Dumesic","year":"2016","unstructured":"Dumesic DA, Akopians AL, Madrigal VK et al (2016) Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women. J Clin Endocrinol Metab 101(11):4178\u20134188","journal-title":"J Clin Endocrinol Metab"},{"key":"8344_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.steroids.2017.12.009","volume":"130","author":"B Echibur\u00fa","year":"2018","unstructured":"Echibur\u00fa B, P\u00e9rez-Bravo F, Galgani JE et al (2018) Enlarged adipocytes in subcutaneous adipose tissue associated to hyperandrogenism and visceral adipose tissue volume in women with polycystic ovary syndrome. Steroids 130:15\u201321","journal-title":"Steroids"},{"issue":"2","key":"8344_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s40519-018-0481-6","volume":"23","author":"R Barazzoni","year":"2018","unstructured":"Barazzoni R, Gortan Cappellari G, Ragni M et al (2018) Insulin resistance in obesity: an overview of fundamental alterations. Eat Weight Disord 23(2):149\u2013157","journal-title":"Eat Weight Disord"},{"key":"8344_CR37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/978-3-319-48382-5_12","volume":"960","author":"D Yaz\u0131c\u0131","year":"2017","unstructured":"Yaz\u0131c\u0131 D, Sezer H (2017) Insulin resistance, obesity and lipotoxicity. Adv Exp Med Biol 960:277\u2013304","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"8344_CR38","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2174\/15701611113119990125","volume":"12","author":"PP Toth","year":"2014","unstructured":"Toth PP (2014) Insulin resistance, small LDL particles, and risk for atherosclerotic disease. Curr Vasc Pharmacol 12(4):653\u2013657","journal-title":"Curr Vasc Pharmacol"},{"issue":"10","key":"8344_CR39","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3389\/fendo.2019.00222","volume":"10","author":"J Cai","year":"2019","unstructured":"Cai J, Zhang Y, Wang Y et al (2019) High thyroid stimulating hormone level is associated with hyperandrogenism in euthyroid polycystic ovary syndrome (PCOS) women, independent of age, BMI, and thyroid autoimmunity: a cross-sectional analysis. Front Endocrinol (Lausanne) 10(10):222","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"8344_CR40","volume":"63","author":"D Glintborg","year":"2016","unstructured":"Glintborg D (2016) Endocrine and metabolic characteristics in polycystic ovary syndrome. Dan Med J 63(4):B5232","journal-title":"Dan Med J"},{"issue":"2","key":"8344_CR41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0303-7207(01)00662-1","volume":"186","author":"JF Strauss 3rd","year":"2002","unstructured":"Strauss JF 3rd, Wood JR, Christenson LK et al (2002) Strategies to elucidate the mechanism of excessive theca cell androgen production in PCOS. Mol Cell Endocrinol 186(2):183\u2013188","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"8344_CR42","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2024.2352136","volume":"40","author":"Z Ting","year":"2024","unstructured":"Ting Z, Xinghua T, Xiao X et al (2024) The impact of androgen levels on serum metabolic profiles in patients with polycystic ovary syndrome. Gynecol Endocrinol 40(1):2352136","journal-title":"Gynecol Endocrinol"},{"key":"8344_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2022.109061","volume":"185","author":"W Tao","year":"2022","unstructured":"Tao W, Cai X, Al Masri MK et al (2022) The effect of transdermal 17\u03b2-estradiol combined with norethisterone acetate treatment on the lipid profile in postmenopausal women: a meta-analysis and systematic review of randomized controlled trials. Steroids 185:109061","journal-title":"Steroids"},{"issue":"2","key":"8344_CR44","doi-asserted-by":"publisher","first-page":"155","DOI":"10.23736\/S0026-4784.18.04330-7","volume":"71","author":"D Nasioudis","year":"2019","unstructured":"Nasioudis D, Doulaveris G, Kanninen TT (2019) Dyslipidemia in pregnancy and maternal-fetal outcome. Minerva Ginecol 71(2):155\u2013162","journal-title":"Minerva Ginecol"},{"issue":"3","key":"8344_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.1947","volume":"7","author":"F Yang","year":"2024","unstructured":"Yang F, Mao W, Ge YM et al (2024) Hyperlipidemia is negatively associated with pregnancy outcomes in patients following frozen-thawed embryo transfer: a retrospective study. Health Sci Rep 7(3):e1947","journal-title":"Health Sci Rep"},{"issue":"1","key":"8344_CR46","doi-asserted-by":"publisher","first-page":"10800","DOI":"10.1038\/s41598-024-61119-x","volume":"14","author":"Y Lv","year":"2024","unstructured":"Lv Y, Xu L, He Z et al (2024) The association between pregnancy levels of blood lipids and the risk of preterm birth. Sci Rep 14(1):10800","journal-title":"Sci Rep"},{"issue":"4","key":"8344_CR47","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.rbmo.2022.04.013","volume":"45","author":"WY Cai","year":"2022","unstructured":"Cai WY, Luo X, Ma HL et al (2022) Association between preconception serum lipid concentrations and treatment outcomes in women with PCOS who underwent ovulation induction. Reprod Biomed Online 45(4):805\u2013814","journal-title":"Reprod Biomed Online"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08344-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-026-08344-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08344-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:04:34Z","timestamp":1771430674000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-026-08344-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8344"],"URL":"https:\/\/doi.org\/10.1007\/s00404-026-08344-z","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,15]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of The First College of Clinical Medical Science, China Three Gorges University (Yichang Central People\u2019s Hospital).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the authors gave written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All the authors have agreed to publish.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"97"}}